Member Biography

My research program in nano-enabled myeloid therapeutics integrates molecular engineering with cancer immunology to design precision nanotechnologies that enhance radiotherapy responsiveness and prevent relapse. My goal is to define and therapeutically reprogram the functional and phenotypic heterogeneity of myeloid cells, which are central coordinators of innate and adaptive immune responses during cancer therapy.